IDH2 and glioblastoma: To validate RTK2-CIMP in an external glioblastoma cohort, we annotated N=131 IDH-wildtype glioblastoma samples from The Cancer Genome Atlas (TCGA) cohort as MES, RTK1, and RTK2 subtypes based on DNA methylation, as described previously [37].